Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses-Reference-Cited by-同舟云学术

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Published:2021-10-11 Issue:12 Volume:9 Page:1465-1475
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Bu Xia,Juneja Vikram R.,Reynolds Carol G.,Mahoney Kathleen M.^ORCID,Bu Melissa T.^ORCID,McGuire Kathleen A.,Maleri Seth,Hua Ping,Zhu Baogong,Klein Sarah R.,Greenfield Edward A.,Armand Philippe,Ritz Jerome^ORCID,Sharpe Arlene H.,Freeman Gordon J.^ORCID

Funder

National Institutes of Health

National Science Foundation

Department of Defense

Cancer Research Institute

Claudia Adams Barr Program for Innovative Cancer Research

Kidney Cancer Association

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma;Cancer and Metastasis Reviews;2024-02-27

2. PD‐1: A critical player and target for immune normalization;Immunology;2024-01-25

3. Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer;Science Advances;2023-05-26

4. Identification of novel immune ferroptosis-related genes associated with clinical and prognostic features in breast cancer;Frontiers in Genetics;2023-04-12

5. Functional binding of PD1 ligands predicts response to anti-PD1 treatment in cancer patients;2023-02-12